Apparent versus true resistant hypertension in a real-world argentine cohort. Abstract Resistant hypertension is frequently overdiagnosed when based exclusively on office blood pressure measurements. In a large real-world cohort from Argentina, ambulatory blood pressure monitoring (ABPM) and evaluation of treatment adequacy reduced the prevalence of resistant hypertension from 12.2% to 5.8%, with inadequate pharmacological therapy and white-coat effect being the main contributors to pseudoresistance.
These findings support systematic use of ABPM and optimization of antihypertensive treatment before labeling patients as truly resistant. This is a preview of subscription content, access via your institution Access options Access through your institution 00 per year only $9.92 per issue Learn more Buy this article Purchase on SpringerLink Instant access to the full article PDF. USD 39.95 Prices may be subject to local taxes which are calculated during checkout Fig.
1: Patient screening and classification flowchart. Explore related subjects Discover the latest articles and news in related subjects. Cardiovascular diseases Diagnosis Hypertension Data availability Additional data are available from the corresponding author on reasonable request.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with qualified healthcare professionals for medical decisions and treatment options.
Discover more from ChuckysCarnage
Subscribe to get the latest posts sent to your email.
